This standard clarifies the basic requirements for the immunogenicity and immunotoxicity of cell therapy products. This standard is applicable to the immunogenicity and immunotoxicity evaluation of cell therapy products.
T/SDHCST 008-2023 history
2023T/SDHCST 008-2023 Procedures for Immunogenicity and Immunotoxicity of the Cell Therapy Medical Products
2022T/SDHCST 008-2022 Raw Material for Special Medical Use Formula Foods - Highly Dispersed Soy Protein Isolate